Pharma & Healthcare
Intravenous (IV) Iron Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 550026
- Pages: 108
- Figures: 206
- Views: 4
The global market for Intravenous (IV) Iron Drugs was estimated to be worth US$ 100.8 million in 2023 and is forecast to a readjusted size of US$ 172.4 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Iron Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Intravenous (IV) Iron Drugs by region & country, by Type, and by Application.
The Intravenous (IV) Iron Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Iron Drugs.
Market Segmentation
By Company
Sanofi US
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
Segment by Type:
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others
Segment by Application
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Intravenous (IV) Iron Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Intravenous (IV) Iron Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Intravenous (IV) Iron Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Iron Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Intravenous (IV) Iron Drugs by region & country, by Type, and by Application.
The Intravenous (IV) Iron Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Iron Drugs.
Market Segmentation
By Company
Sanofi US
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
Segment by Type:
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others
Segment by Application
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Intravenous (IV) Iron Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Intravenous (IV) Iron Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Intravenous (IV) Iron Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Intravenous (IV) Iron Drugs Product Introduction
1.2 Global Intravenous (IV) Iron Drugs Market Size Forecast
1.2.1 Global Intravenous (IV) Iron Drugs Sales Value (2019-2030)
1.2.2 Global Intravenous (IV) Iron Drugs Sales Volume (2019-2030)
1.2.3 Global Intravenous (IV) Iron Drugs Sales Price (2019-2030)
1.3 Intravenous (IV) Iron Drugs Market Trends & Drivers
1.3.1 Intravenous (IV) Iron Drugs Industry Trends
1.3.2 Intravenous (IV) Iron Drugs Market Drivers & Opportunity
1.3.3 Intravenous (IV) Iron Drugs Market Challenges
1.3.4 Intravenous (IV) Iron Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Intravenous (IV) Iron Drugs Players Revenue Ranking (2023)
2.2 Global Intravenous (IV) Iron Drugs Revenue by Company (2019-2024)
2.3 Global Intravenous (IV) Iron Drugs Players Sales Volume Ranking (2023)
2.4 Global Intravenous (IV) Iron Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Intravenous (IV) Iron Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Intravenous (IV) Iron Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Intravenous (IV) Iron Drugs
2.9 Intravenous (IV) Iron Drugs Market Competitive Analysis
2.9.1 Intravenous (IV) Iron Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Intravenous (IV) Iron Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ferric Carboxymaltose
3.1.2 Iron Sucrose
3.1.3 Iron Dextran
3.1.4 Others
3.2 Global Intravenous (IV) Iron Drugs Sales Value by Type
3.2.1 Global Intravenous (IV) Iron Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Intravenous (IV) Iron Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Intravenous (IV) Iron Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Intravenous (IV) Iron Drugs Sales Volume by Type
3.3.1 Global Intravenous (IV) Iron Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Intravenous (IV) Iron Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Intravenous (IV) Iron Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Intravenous (IV) Iron Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Nephrology
4.1.2 Gynecology & Obstetrics
4.1.3 Gastroenterology
4.1.4 Oncology
4.1.5 Cardiology
4.1.6 Others
4.2 Global Intravenous (IV) Iron Drugs Sales Value by Application
4.2.1 Global Intravenous (IV) Iron Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Intravenous (IV) Iron Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Intravenous (IV) Iron Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Intravenous (IV) Iron Drugs Sales Volume by Application
4.3.1 Global Intravenous (IV) Iron Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Intravenous (IV) Iron Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Intravenous (IV) Iron Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Intravenous (IV) Iron Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Intravenous (IV) Iron Drugs Sales Value by Region
5.1.1 Global Intravenous (IV) Iron Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Intravenous (IV) Iron Drugs Sales Value by Region (2019-2024)
5.1.3 Global Intravenous (IV) Iron Drugs Sales Value by Region (2025-2030)
5.1.4 Global Intravenous (IV) Iron Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Intravenous (IV) Iron Drugs Sales Volume by Region
5.2.1 Global Intravenous (IV) Iron Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Intravenous (IV) Iron Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Intravenous (IV) Iron Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Intravenous (IV) Iron Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Intravenous (IV) Iron Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.4.2 North America Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.5.2 Europe Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.7.2 South America Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value
6.2.1 Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Intravenous (IV) Iron Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.3.2 United States Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.4.2 Europe Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.5.2 China Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.6.2 Japan Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.7.2 South Korea Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.9.2 India Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi US
7.1.1 Sanofi US Company Information
7.1.2 Sanofi US Introduction and Business Overview
7.1.3 Sanofi US Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi US Intravenous (IV) Iron Drugs Product Offerings
7.1.5 Sanofi US Recent Development
7.2 Allergan
7.2.1 Allergan Company Information
7.2.2 Allergan Introduction and Business Overview
7.2.3 Allergan Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Allergan Intravenous (IV) Iron Drugs Product Offerings
7.2.5 Allergan Recent Development
7.3 AMAG Pharmaceuticals
7.3.1 AMAG Pharmaceuticals Company Information
7.3.2 AMAG Pharmaceuticals Introduction and Business Overview
7.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Offerings
7.3.5 AMAG Pharmaceuticals Recent Development
7.4 Dalichi Sankyo
7.4.1 Dalichi Sankyo Company Information
7.4.2 Dalichi Sankyo Introduction and Business Overview
7.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Dalichi Sankyo Intravenous (IV) Iron Drugs Product Offerings
7.4.5 Dalichi Sankyo Recent Development
7.5 Luitpold Pharmaceuticals
7.5.1 Luitpold Pharmaceuticals Company Information
7.5.2 Luitpold Pharmaceuticals Introduction and Business Overview
7.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Offerings
7.5.5 Luitpold Pharmaceuticals Recent Development
7.6 Pharmacosmos
7.6.1 Pharmacosmos Company Information
7.6.2 Pharmacosmos Introduction and Business Overview
7.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pharmacosmos Intravenous (IV) Iron Drugs Product Offerings
7.6.5 Pharmacosmos Recent Development
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Company Information
7.7.2 Takeda Pharmaceutical Introduction and Business Overview
7.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Offerings
7.7.5 Takeda Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Intravenous (IV) Iron Drugs Industrial Chain
8.2 Intravenous (IV) Iron Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Intravenous (IV) Iron Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Intravenous (IV) Iron Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Intravenous (IV) Iron Drugs Product Introduction
1.2 Global Intravenous (IV) Iron Drugs Market Size Forecast
1.2.1 Global Intravenous (IV) Iron Drugs Sales Value (2019-2030)
1.2.2 Global Intravenous (IV) Iron Drugs Sales Volume (2019-2030)
1.2.3 Global Intravenous (IV) Iron Drugs Sales Price (2019-2030)
1.3 Intravenous (IV) Iron Drugs Market Trends & Drivers
1.3.1 Intravenous (IV) Iron Drugs Industry Trends
1.3.2 Intravenous (IV) Iron Drugs Market Drivers & Opportunity
1.3.3 Intravenous (IV) Iron Drugs Market Challenges
1.3.4 Intravenous (IV) Iron Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Intravenous (IV) Iron Drugs Players Revenue Ranking (2023)
2.2 Global Intravenous (IV) Iron Drugs Revenue by Company (2019-2024)
2.3 Global Intravenous (IV) Iron Drugs Players Sales Volume Ranking (2023)
2.4 Global Intravenous (IV) Iron Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Intravenous (IV) Iron Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Intravenous (IV) Iron Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Intravenous (IV) Iron Drugs
2.9 Intravenous (IV) Iron Drugs Market Competitive Analysis
2.9.1 Intravenous (IV) Iron Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Intravenous (IV) Iron Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ferric Carboxymaltose
3.1.2 Iron Sucrose
3.1.3 Iron Dextran
3.1.4 Others
3.2 Global Intravenous (IV) Iron Drugs Sales Value by Type
3.2.1 Global Intravenous (IV) Iron Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Intravenous (IV) Iron Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Intravenous (IV) Iron Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Intravenous (IV) Iron Drugs Sales Volume by Type
3.3.1 Global Intravenous (IV) Iron Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Intravenous (IV) Iron Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Intravenous (IV) Iron Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Intravenous (IV) Iron Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Nephrology
4.1.2 Gynecology & Obstetrics
4.1.3 Gastroenterology
4.1.4 Oncology
4.1.5 Cardiology
4.1.6 Others
4.2 Global Intravenous (IV) Iron Drugs Sales Value by Application
4.2.1 Global Intravenous (IV) Iron Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Intravenous (IV) Iron Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Intravenous (IV) Iron Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Intravenous (IV) Iron Drugs Sales Volume by Application
4.3.1 Global Intravenous (IV) Iron Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Intravenous (IV) Iron Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Intravenous (IV) Iron Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Intravenous (IV) Iron Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Intravenous (IV) Iron Drugs Sales Value by Region
5.1.1 Global Intravenous (IV) Iron Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Intravenous (IV) Iron Drugs Sales Value by Region (2019-2024)
5.1.3 Global Intravenous (IV) Iron Drugs Sales Value by Region (2025-2030)
5.1.4 Global Intravenous (IV) Iron Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Intravenous (IV) Iron Drugs Sales Volume by Region
5.2.1 Global Intravenous (IV) Iron Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Intravenous (IV) Iron Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Intravenous (IV) Iron Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Intravenous (IV) Iron Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Intravenous (IV) Iron Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.4.2 North America Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.5.2 Europe Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.7.2 South America Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Intravenous (IV) Iron Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value
6.2.1 Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Intravenous (IV) Iron Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.3.2 United States Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.4.2 Europe Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.5.2 China Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.6.2 Japan Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.7.2 South Korea Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Intravenous (IV) Iron Drugs Sales Value, 2019-2030
6.9.2 India Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Intravenous (IV) Iron Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi US
7.1.1 Sanofi US Company Information
7.1.2 Sanofi US Introduction and Business Overview
7.1.3 Sanofi US Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi US Intravenous (IV) Iron Drugs Product Offerings
7.1.5 Sanofi US Recent Development
7.2 Allergan
7.2.1 Allergan Company Information
7.2.2 Allergan Introduction and Business Overview
7.2.3 Allergan Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Allergan Intravenous (IV) Iron Drugs Product Offerings
7.2.5 Allergan Recent Development
7.3 AMAG Pharmaceuticals
7.3.1 AMAG Pharmaceuticals Company Information
7.3.2 AMAG Pharmaceuticals Introduction and Business Overview
7.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Offerings
7.3.5 AMAG Pharmaceuticals Recent Development
7.4 Dalichi Sankyo
7.4.1 Dalichi Sankyo Company Information
7.4.2 Dalichi Sankyo Introduction and Business Overview
7.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Dalichi Sankyo Intravenous (IV) Iron Drugs Product Offerings
7.4.5 Dalichi Sankyo Recent Development
7.5 Luitpold Pharmaceuticals
7.5.1 Luitpold Pharmaceuticals Company Information
7.5.2 Luitpold Pharmaceuticals Introduction and Business Overview
7.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Offerings
7.5.5 Luitpold Pharmaceuticals Recent Development
7.6 Pharmacosmos
7.6.1 Pharmacosmos Company Information
7.6.2 Pharmacosmos Introduction and Business Overview
7.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pharmacosmos Intravenous (IV) Iron Drugs Product Offerings
7.6.5 Pharmacosmos Recent Development
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Company Information
7.7.2 Takeda Pharmaceutical Introduction and Business Overview
7.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Offerings
7.7.5 Takeda Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Intravenous (IV) Iron Drugs Industrial Chain
8.2 Intravenous (IV) Iron Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Intravenous (IV) Iron Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Intravenous (IV) Iron Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Intravenous (IV) Iron Drugs Market Trends
Table 2. Intravenous (IV) Iron Drugs Market Drivers & Opportunity
Table 3. Intravenous (IV) Iron Drugs Market Challenges
Table 4. Intravenous (IV) Iron Drugs Market Restraints
Table 5. Global Intravenous (IV) Iron Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Intravenous (IV) Iron Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Intravenous (IV) Iron Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Intravenous (IV) Iron Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Intravenous (IV) Iron Drugs Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Intravenous (IV) Iron Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Intravenous (IV) Iron Drugs
Table 13. Global Intravenous (IV) Iron Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous (IV) Iron Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Intravenous (IV) Iron Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Intravenous (IV) Iron Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Intravenous (IV) Iron Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Intravenous (IV) Iron Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Intravenous (IV) Iron Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Intravenous (IV) Iron Drugs Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Intravenous (IV) Iron Drugs Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Intravenous (IV) Iron Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Intravenous (IV) Iron Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Intravenous (IV) Iron Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Intravenous (IV) Iron Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Intravenous (IV) Iron Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Intravenous (IV) Iron Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Intravenous (IV) Iron Drugs Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Intravenous (IV) Iron Drugs Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Intravenous (IV) Iron Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Intravenous (IV) Iron Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Intravenous (IV) Iron Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Intravenous (IV) Iron Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Intravenous (IV) Iron Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Intravenous (IV) Iron Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Intravenous (IV) Iron Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Intravenous (IV) Iron Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Intravenous (IV) Iron Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Intravenous (IV) Iron Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Intravenous (IV) Iron Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Intravenous (IV) Iron Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Sanofi US Company Information
Table 58. Sanofi US Introduction and Business Overview
Table 59. Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Sanofi US Intravenous (IV) Iron Drugs Product Offerings
Table 61. Sanofi US Recent Development
Table 62. Allergan Company Information
Table 63. Allergan Introduction and Business Overview
Table 64. Allergan Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Allergan Intravenous (IV) Iron Drugs Product Offerings
Table 66. Allergan Recent Development
Table 67. AMAG Pharmaceuticals Company Information
Table 68. AMAG Pharmaceuticals Introduction and Business Overview
Table 69. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Offerings
Table 71. AMAG Pharmaceuticals Recent Development
Table 72. Dalichi Sankyo Company Information
Table 73. Dalichi Sankyo Introduction and Business Overview
Table 74. Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Dalichi Sankyo Intravenous (IV) Iron Drugs Product Offerings
Table 76. Dalichi Sankyo Recent Development
Table 77. Luitpold Pharmaceuticals Company Information
Table 78. Luitpold Pharmaceuticals Introduction and Business Overview
Table 79. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Offerings
Table 81. Luitpold Pharmaceuticals Recent Development
Table 82. Pharmacosmos Company Information
Table 83. Pharmacosmos Introduction and Business Overview
Table 84. Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Pharmacosmos Intravenous (IV) Iron Drugs Product Offerings
Table 86. Pharmacosmos Recent Development
Table 87. Takeda Pharmaceutical Company Information
Table 88. Takeda Pharmaceutical Introduction and Business Overview
Table 89. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Offerings
Table 91. Takeda Pharmaceutical Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Intravenous (IV) Iron Drugs Downstream Customers
Table 95. Intravenous (IV) Iron Drugs Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous (IV) Iron Drugs Product Picture
Figure 2. Global Intravenous (IV) Iron Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Intravenous (IV) Iron Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Intravenous (IV) Iron Drugs Sales Price (2019-2030) & (USD/Unit)
Figure 6. Intravenous (IV) Iron Drugs Report Years Considered
Figure 7. Global Intravenous (IV) Iron Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Intravenous (IV) Iron Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous (IV) Iron Drugs Revenue in 2023
Figure 10. Intravenous (IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Ferric Carboxymaltose Picture
Figure 12. Iron Sucrose Picture
Figure 13. Iron Dextran Picture
Figure 14. Others Picture
Figure 15. Global Intravenous (IV) Iron Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Intravenous (IV) Iron Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Intravenous (IV) Iron Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Intravenous (IV) Iron Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Intravenous (IV) Iron Drugs Price by Type (2019-2030) & (USD/Unit)
Figure 20. Product Picture of Nephrology
Figure 21. Product Picture of Gynecology & Obstetrics
Figure 22. Product Picture of Gastroenterology
Figure 23. Product Picture of Oncology
Figure 24. Product Picture of Cardiology
Figure 25. Product Picture of Others
Figure 26. Global Intravenous (IV) Iron Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Intravenous (IV) Iron Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Intravenous (IV) Iron Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 29. Global Intravenous (IV) Iron Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Intravenous (IV) Iron Drugs Price by Application (2019-2030) & (USD/Unit)
Figure 31. North America Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Volume (%), (2019-2030)
Figure 43. United States Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. China Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. China Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 61. India Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 63. India Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 64. Intravenous (IV) Iron Drugs Industrial Chain
Figure 65. Intravenous (IV) Iron Drugs Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Intravenous (IV) Iron Drugs Market Trends
Table 2. Intravenous (IV) Iron Drugs Market Drivers & Opportunity
Table 3. Intravenous (IV) Iron Drugs Market Challenges
Table 4. Intravenous (IV) Iron Drugs Market Restraints
Table 5. Global Intravenous (IV) Iron Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Intravenous (IV) Iron Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Intravenous (IV) Iron Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Intravenous (IV) Iron Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Intravenous (IV) Iron Drugs Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Intravenous (IV) Iron Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Intravenous (IV) Iron Drugs
Table 13. Global Intravenous (IV) Iron Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous (IV) Iron Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Intravenous (IV) Iron Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Intravenous (IV) Iron Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Intravenous (IV) Iron Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Intravenous (IV) Iron Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Intravenous (IV) Iron Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Intravenous (IV) Iron Drugs Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Intravenous (IV) Iron Drugs Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Intravenous (IV) Iron Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Intravenous (IV) Iron Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Intravenous (IV) Iron Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Intravenous (IV) Iron Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Intravenous (IV) Iron Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Intravenous (IV) Iron Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Intravenous (IV) Iron Drugs Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Intravenous (IV) Iron Drugs Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Intravenous (IV) Iron Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Intravenous (IV) Iron Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Intravenous (IV) Iron Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Intravenous (IV) Iron Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Intravenous (IV) Iron Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Intravenous (IV) Iron Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Intravenous (IV) Iron Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Intravenous (IV) Iron Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Intravenous (IV) Iron Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Intravenous (IV) Iron Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Intravenous (IV) Iron Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Intravenous (IV) Iron Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Sanofi US Company Information
Table 58. Sanofi US Introduction and Business Overview
Table 59. Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Sanofi US Intravenous (IV) Iron Drugs Product Offerings
Table 61. Sanofi US Recent Development
Table 62. Allergan Company Information
Table 63. Allergan Introduction and Business Overview
Table 64. Allergan Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Allergan Intravenous (IV) Iron Drugs Product Offerings
Table 66. Allergan Recent Development
Table 67. AMAG Pharmaceuticals Company Information
Table 68. AMAG Pharmaceuticals Introduction and Business Overview
Table 69. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Offerings
Table 71. AMAG Pharmaceuticals Recent Development
Table 72. Dalichi Sankyo Company Information
Table 73. Dalichi Sankyo Introduction and Business Overview
Table 74. Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Dalichi Sankyo Intravenous (IV) Iron Drugs Product Offerings
Table 76. Dalichi Sankyo Recent Development
Table 77. Luitpold Pharmaceuticals Company Information
Table 78. Luitpold Pharmaceuticals Introduction and Business Overview
Table 79. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Offerings
Table 81. Luitpold Pharmaceuticals Recent Development
Table 82. Pharmacosmos Company Information
Table 83. Pharmacosmos Introduction and Business Overview
Table 84. Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Pharmacosmos Intravenous (IV) Iron Drugs Product Offerings
Table 86. Pharmacosmos Recent Development
Table 87. Takeda Pharmaceutical Company Information
Table 88. Takeda Pharmaceutical Introduction and Business Overview
Table 89. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Offerings
Table 91. Takeda Pharmaceutical Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Intravenous (IV) Iron Drugs Downstream Customers
Table 95. Intravenous (IV) Iron Drugs Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous (IV) Iron Drugs Product Picture
Figure 2. Global Intravenous (IV) Iron Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Intravenous (IV) Iron Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Intravenous (IV) Iron Drugs Sales Price (2019-2030) & (USD/Unit)
Figure 6. Intravenous (IV) Iron Drugs Report Years Considered
Figure 7. Global Intravenous (IV) Iron Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Intravenous (IV) Iron Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous (IV) Iron Drugs Revenue in 2023
Figure 10. Intravenous (IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Ferric Carboxymaltose Picture
Figure 12. Iron Sucrose Picture
Figure 13. Iron Dextran Picture
Figure 14. Others Picture
Figure 15. Global Intravenous (IV) Iron Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Intravenous (IV) Iron Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Intravenous (IV) Iron Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Intravenous (IV) Iron Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Intravenous (IV) Iron Drugs Price by Type (2019-2030) & (USD/Unit)
Figure 20. Product Picture of Nephrology
Figure 21. Product Picture of Gynecology & Obstetrics
Figure 22. Product Picture of Gastroenterology
Figure 23. Product Picture of Oncology
Figure 24. Product Picture of Cardiology
Figure 25. Product Picture of Others
Figure 26. Global Intravenous (IV) Iron Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Intravenous (IV) Iron Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Intravenous (IV) Iron Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 29. Global Intravenous (IV) Iron Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Intravenous (IV) Iron Drugs Price by Application (2019-2030) & (USD/Unit)
Figure 31. North America Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Intravenous (IV) Iron Drugs Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Intravenous (IV) Iron Drugs Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Intravenous (IV) Iron Drugs Sales Volume (%), (2019-2030)
Figure 43. United States Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. China Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. China Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 61. India Intravenous (IV) Iron Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Intravenous (IV) Iron Drugs Sales Value by Type (%), 2023 VS 2030
Figure 63. India Intravenous (IV) Iron Drugs Sales Value by Application (%), 2023 VS 2030
Figure 64. Intravenous (IV) Iron Drugs Industrial Chain
Figure 65. Intravenous (IV) Iron Drugs Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232